172 related articles for article (PubMed ID: 7622464)
21. Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A.
Uehara Y; Murakami Y; Mizuno S; Kawai S
Virology; 1988 May; 164(1):294-8. PubMed ID: 2452516
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin.
Yen CH; Yang YC; Ruscetti SK; Kirken RA; Dai RM; Li CC
J Immunol; 2000 Dec; 165(11):6372-80. PubMed ID: 11086075
[TBL] [Abstract][Full Text] [Related]
24. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
25. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.
An WG; Schulte TW; Neckers LM
Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589
[TBL] [Abstract][Full Text] [Related]
26. 19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cells.
Makishima M; Yamamoto-Yamaguchi Y; Honma Y
Biochim Biophys Acta; 1995 Dec; 1272(3):199-205. PubMed ID: 8541353
[TBL] [Abstract][Full Text] [Related]
27. Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):57-62. PubMed ID: 8037691
[TBL] [Abstract][Full Text] [Related]
28. Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines.
Sato S; Honma Y; Hozumi M; Hayashi Y; Matsuo Y; Shibata K; Omura S; Hino K; Tomoyasu S; Tsuruoka N
Leuk Res; 1994 Mar; 18(3):221-8. PubMed ID: 8139288
[TBL] [Abstract][Full Text] [Related]
29. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells.
Okabe M; Kawamura K; Miyagishima T; Itaya T; Goodwyn D; Shoji M; Vogler WR; Sakurada K; Uehara M; Miyazaki T
Leuk Res; 1994 Mar; 18(3):213-20. PubMed ID: 7511193
[TBL] [Abstract][Full Text] [Related]
30. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
Zhou M; Fisher EA; Ginsberg HN
J Biol Chem; 1998 Sep; 273(38):24649-53. PubMed ID: 9733761
[TBL] [Abstract][Full Text] [Related]
31. Neurite outgrowth stimulated by the tyrosine kinase inhibitor herbimycin A requires activation of tyrosine kinases and protein kinase C.
Doherty P; Furness J; Williams EJ; Walsh FS
J Neurochem; 1994 Jun; 62(6):2124-31. PubMed ID: 7514647
[TBL] [Abstract][Full Text] [Related]
32. Herbimycin A inhibits phorbol ester-induced morphologic changes, adhesion, and megakaryocytic differentiation of the leukemia cell line, MEG-01.
Murate T; Saga S; Hamaguchi M; Asano H; Ito T; Watanabe T; Adachi K; Koizumi KT; Yoshida S; Saito H
Proc Soc Exp Biol Med; 1995 Jul; 209(3):270-8. PubMed ID: 7539928
[TBL] [Abstract][Full Text] [Related]
33. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin.
Mimnaugh EG; Chavany C; Neckers L
J Biol Chem; 1996 Sep; 271(37):22796-801. PubMed ID: 8798456
[TBL] [Abstract][Full Text] [Related]
34. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome?
Pallarés-Trujillo J; Carbó N; López-Soriano FJ; Argilés JM
Med Hypotheses; 2000 Apr; 54(4):565-9. PubMed ID: 10859639
[TBL] [Abstract][Full Text] [Related]
35. Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes.
Murakami Y; Uehara Y; Yamamoto C; Fukazawa H; Mizuno S
Exp Cell Res; 1991 Aug; 195(2):338-44. PubMed ID: 2070817
[TBL] [Abstract][Full Text] [Related]
36. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
Blair HC; Jordan SE; Peterson TG; Barnes S
J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
[TBL] [Abstract][Full Text] [Related]
37. In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in mice bearing BCR/ABL-transfected cells.
Okabe M; Uehara Y; Noshima T; Itaya T; Kunieda Y; Kurosawa M
Leuk Res; 1994 Nov; 18(11):867-73. PubMed ID: 7967714
[TBL] [Abstract][Full Text] [Related]
38. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
Schulte TW; An WG; Neckers LM
Biochem Biophys Res Commun; 1997 Oct; 239(3):655-9. PubMed ID: 9367823
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
40. Genistein inhibits herbimycin A-induced over-expression of inducible heat shock protein 70 kDa.
Kiang JG
Mol Cell Biochem; 2003 Mar; 245(1-2):191-9. PubMed ID: 12708759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
